Relations of a marker of endothelial activation (s-VCAM) to function and mortality in community-dwelling older adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 12, 2011, Pages 1369-1375

  Huffman, Kim M ^a,b,c,d   Pieper, Carl F ^c   Kraus, Virginia B ^b,c   Kraus, William E ^c,d   Fillenbaum, Gerda G ^a,c   Cohen, Harvey J ^c  

^a DURHAM VA MEDICAL CENTER   (United States)

^b Division of Rheumatology   (United States)

^c Center for Aging and Human Development   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

D dimer; IL 6; S VCAM

Indexed keywords

BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

AGED; AGING; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; MORTALITY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; SOLUBILITY; UNITED STATES; VASCULAR ENDOTHELIUM;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NORTH CAROLINA; RESIDENCE CHARACTERISTICS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 81055144383     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr121     Document Type: Article

References (40)

1. Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylha M. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol Sci Med Sci. 2010;65:658-663.
2. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci. 2006;61:575-584.
3. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997;52:M201-M208. (Pubitemid 27347153)
4. Pieper CF, Rao KM, Currie MS, Harris TB, Chen HJ. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci. 2000;55:M649-M657. (Pubitemid 32010310)
5. Reuben DB, Cheh AI, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc. 2002;50:638-644. (Pubitemid 34298751)
6. Walston J, McBurnie MA, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162:2333-2341. (Pubitemid 35332516)
7. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512. (Pubitemid 29231100)
8. Volpato S, Guralnik JM, Ferrucci L, et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation. 2001;103:947-953. (Pubitemid 32183799)
9. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:180-187. (Pubitemid 36294002)
10. Jylha M, Paavilainen P, Lehtimaki T, et al. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci. 2007;62:1016-1021. (Pubitemid 47531219)
11. Gomez JM, Vila R, Catalina P, Soler J, Badimon L, Sahun M. The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives. Glycoconj J. 2008;25:573-579.
12. Ursavas A, Karadag M, Rodoplu E, Yilmaztepe A, Oral HB, Gozu RO. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration. 2007;74:525-532. (Pubitemid 47206882)
13. Blanco M, Sobrino T, Montaner J, et al. Stroke with polyvascular atherothrombotic disease. Atherosclerosis. 2010;208:587-592.
14. Zuliani G, Cavalieri M, Galvani M, et al. Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J Neurol Sci. 2008;272:164-170.
15. Alexiou D, Karayiannakis AJ, Syrigos KN, et al. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol. 2003;98:478-485. (Pubitemid 36232403)
16. Schett G, Kiechl S, Bonora E, et al. Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. Arthritis Rheum. 2009;60:2381-2389.
17. Carter RA, Wicks IP. Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum. 2001;44:985-994. (Pubitemid 32433601)
18. Kato GJ, Martyr S, Blackwelder WC, et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol. 2005;130:943-953. (Pubitemid 43899735)
19. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584-589.
20. Kitani A, Nakashima N, Izumihara T, et al. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol. 1998;161:4931-4938. (Pubitemid 28492073)
21. Vanderstocken G, Bondue B, Horckmans M, et al. P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation. J Immunol. 2010;185:3702-3707.
22. Currie MS, Rao MK, Blazer DG, Cohen HJ. Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers). J Am Geriatr Soc. 1994;42:738-742. (Pubitemid 24213195)
23. Cornoni-Huntley J, Blazer DG, Lafferty ME, Everett DF, Brock DB, Farmer ME. Established Populations for Epidemiologic Studies of the Elderly, Volume II: Resource Data Book. Washington, DC: US Department of Health and Human Services, PHS, National Institutes of Health; 1990.
24. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20-30.
25. Rosow I, Breslau NA. Guttman health scale for the aged. J Gerontol. 1966;21:556-559.
26. Nagi SZ. An epidemiology measure of disability among adults in the United States. Milbank Memorial Fund Q. 1976;54:439-467.
27. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:433-441.
28. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:355-401.
29. Blazer D, Burchett B, Service C, George LK. The association of age and depression among the elderly: an epidemiologic exploration. J Gerontol. 1991;46:M210-M215.
30. Wilson CJ, Cohen HJ, Pieper CF. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am Geriatr Soc. 2003;51:1374-1381. (Pubitemid 37259865)
31. Fillenbaum GG, Burchett BM, Blazer DG. Identifying a national death index match. Am J Epidemiol. 2009;170:515-518.
32. Kleinbaum D, Kupper D, Muller K. Applied Regression Analysis and Other Multivariable Analysis, 2nd ed. Boston, MA: PWS-Kent; 1988.
33. Singer J, Willett J. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003.
34. Blankenberg S, Rupprecht HJ, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation. 2001;104:1336-1342. (Pubitemid 32880144)
35. Jager A, van Hinsbergh VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes. 2000;49:485-491. (Pubitemid 30131796)
36. Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci. 2010;65:1028-1041.
37. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond). 2011;120:357-375.
38. Rao KM, Pieper CS, Currie MS, Cohen HJ. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol. 1994;102:802-805.
39. Elovaara I, Ukkonen M, Leppakynnas M, et al. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy. Arch Neurol. 2000;57:546-551. (Pubitemid 30212129)
40. Tso TK, Huang WN. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance. J Rheumatol. 2007;34:726-730. (Pubitemid 46641377)